Skip to main content

Featured Article of the Month

p53 aberration and TFE3 gene amplification may be predictors of adverse prognosis in epithelioid angiomyolipoma of the kidney

Although epithelioid angiomyolipoma of the kidney has been studied by several groups, the reported prevalence of malignant behavior remains uncertain and there are not yet definitive predictive biomarkers. We evaluated the behavior of renal epithelioid angiomyolipoma in a consecutive series in a single institution and investigated the prognostic value of aberrant p53 expression and TFE3 gene abnormality.


Featured Image of the Month

New Content Item

Global Advances in AI: Innovations in Digital Pathology and Radiology 2022

Kameda Medical Center (Japan), Nagasaki University (Japan) and The Ohio State University (USA) are teaming up to present a virtual joint conference on Global Advances in AI: Innovations in Digital Pathology and Radiology 2022. International speakers will share up-to-date information on AI development in pathology and radiology.

Latest Tweets

Your browser needs to have JavaScript enabled to view this timeline

Artificial Intelligence in Cancer Imaging and Diagnosis

New tools and technologies such as computational and digital pathology, molecular diagnostics and artificial intelligence (AI) are making their way into advanced clinical diagnostics, providing some unique opportunities to incorporate these tools into the evolving health care landscape.  We're proud to present a cross journal series with articles that would give the viewer a perspective of the current trends and future prospects of AI primarily in clinical diagnostics. Read here.

Dr Anil Parwani, Editor-in-Chief

"Diagnostic Pathology has emerged as a premier journal that aims to publish cutting edge articles focused on diagnostic pathology with an emphasis on novel morphological and molecular findings that make an impact on diagnosis of neoplastic and non-neoplastic diseases. The goal of the editorial board and our team is to highlight the cross-roads of diagnostic pathology and new tools and technologies that are exciting, challenging and making an impact on the practice of pathology. We will continue to bring updates in the field of diagnostic pathology by way of novel and interesting case reports, research and original articles and a series of key review articles by experts in the field that will emphasize the new developments which are disease-specific and highlight contemporary and novel technologies that are changing the practice of diagnostic pathology. This is an exciting time in pathology as we are confronted with a new frontier of science and technology which continues to evolve and accelerate the discipline of diagnostic pathology and we wish to take our readers with us on this exciting journey. We want to collaborate with our reviewers and our readers to make Diagnostic Pathology a premier and trusted source of new and exciting developments in the field of diagnostic pathology."

Dr Anil Parwani, Ohio State University​​​​​​​

Annual Journal Metrics